These side effects have been notably milder when compared to an inhibitor of each bromodomains. A detailed molecular Investigation also exposed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ? Stephen Taylor then market H3K27Ac at this area.